Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Healthtrust
Fish and Richardson
Harvard Business School
Merck
Mallinckrodt
US Army
Accenture
Argus Health
Novartis

Generated: October 17, 2017

DrugPatentWatch Database Preview

Mazindol - Generic Drug Details

« Back to Dashboard

What are the generic sources for mazindol and what is the scope of mazindol freedom to operate?

Mazindol
is the generic ingredient in two branded drugs marketed by Novartis and Wyeth Ayerst, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: mazindol

US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Bulk Api Vendors: see list33
Clinical Trials: see list2
Patent Applications: see list4,820
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mazindol at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
MAZANOR
mazindol
TABLET;ORAL017980-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
SANOREX
mazindol
TABLET;ORAL017247-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis
SANOREX
mazindol
TABLET;ORAL017247-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
MAZANOR
mazindol
TABLET;ORAL017980-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mazindol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
SANOREX
mazindol
TABLET;ORAL017247-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
MAZANOR
mazindol
TABLET;ORAL017980-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
MAZANOR
mazindol
TABLET;ORAL017980-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Novartis
SANOREX
mazindol
TABLET;ORAL017247-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Daiichi Sankyo
Chinese Patent Office
Farmers Insurance
Merck
Dow
Johnson and Johnson
Colorcon
UBS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot